NIH-funded research R21 grant

Developing a quick test to diagnose active Hepatitis C infections

Official title: Rapid Antigen Test for Diagnosis of Active HCV Infection

Funded at Rutgers Biomedical and Health Sciences · NIH-11056205 · Data updated 2026-11-12

This study is working on a quick and easy test to help people find out if they have an active Hepatitis C infection, making it simpler for those at risk to get diagnosed and treated right away.

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionRutgers Biomedical and Health Sciences
NIH-funded
Lab location1 site (Newark, UNITED STATES)
Project startJune 18, 2025
Project endMay 31, 2027
Funding year2025
Award (this year)$272,133
NIH project number1R21AI180263-01A1
Project IDNIH-11056205 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals at risk for Hepatitis C infection, including those in low- and middle-income countries and injecting drug users.

Less likely to help

Patients who are already diagnosed and receiving treatment for Hepatitis C may not benefit directly from this research.

What this research studies

This research focuses on creating a rapid antigen test for diagnosing active Hepatitis C virus (HCV) infections, which affect millions globally. The approach involves developing a low-cost, instrument-free test that can be used at the point of care, making it accessible to at-risk populations. By detecting HCV core antigens in the blood, the test aims to identify individuals who are unaware of their infection status, thereby facilitating timely treatment and reducing transmission rates. The methodology includes immunizing mice to produce specific antibodies that can be used in the test.

Why it matters

Potential benefit: If successful, this research could significantly improve early diagnosis and treatment of Hepatitis C, potentially saving lives and reducing the spread of the virus.

How similar studies have gone: Other research has shown promise in developing rapid tests for viral infections, indicating that this approach could be effective for Hepatitis C as well.

Where this research is happening

  • Rutgers Biomedical and Health Sciences
    Newark, United States
    Active

Researchers

  • Principal investigator: Herrera, Bobby Brooke — Rutgers Biomedical and Health Sciences
  • Study coordinator: Herrera, Bobby Brooke

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.